ReCor Medical Company Profile

News Articles [ 14 Associated News Articles listed on BioPortfolio]

ReCor Medical Reports Impressive Six-Month Follow-up Data for Its Ultrasound-Based PARADISEâ„¢ Renal Denervation System for Treating Resistant Hypertension

ReCor Medical, an emerging medical device company, reported today six-month follow-up data on eight patients who have been treated via renal denervation for their resistant...

ReCor Medical Expands Its Medical Advisory Board

Click here for video interviews ReCor Medical announced today that it has expanded its medical advisory board in anticipation of conducting post-market clin...

ReCor Medical begins ACHIEVE post-market study with its Generation-2, ultrasound-based PARADISEâ„¢ renal denervation system

ReCor Medical announced today that it has commenced a 50-patient, post-market study across multiple sites in Europe with its CE-marked next-generation PARADISE system, a m...

ReCor Medical Reports 100% Responder Rate at One-Year Follow-up in Clinical Trial of Its Ultrasound-Based PARADISEâ„¢ Renal Denervation System for Treating Resistant Hypertension, a Major Risk Factor for Cardiovascular Disease

ReCor Medical reported one-year follow-up data on patients who have been treated via renal denervation for their resistant hypertension with the Company’s PARADISE® Syst...

ReCor Medical Receives CE Mark for its Generation 2, Ultrasound-based PARADISEâ„¢ Renal Denervation System

ReCor Medical announced today that it has received CE mark for its next-generation PARADISE system, a minimally invasive 6Fr over-the-wire (OTW) ultrasound device for trea...

ReCor wins EU approval for 2nd-gen renal denervation device

ReCor Medical has been cleared to market a new version of its ultrasound-based renal denervation device, which is used to con -More- 

Postmarket trial begins for ReCor's hypertension device

ReCor Medical has begun patient enrollment for a postmarket trial of the company's Paradise renal denervation technology, a n -More- 

ReCor commences minimally invasive ultrasound device post-market study

ReCor Medical has commenced a post-market Achieve study of its Gen-2 Paradise system, designed for use in patients with resistant high blood pressure.

Drugs and Medications [0 Results]

None

PubMed Articles [ 2 Associated PubMed Articles listed on BioPortfolio]

First experience with endovascular ultrasound renal denervation for the treatment of resistant hypertension.

Aims: To evaluate a novel modality utilising ultrasound for renal denervation designed to reduce the duration of the intervention as well as to increase the consistency of the clinical outcome. Method...

Direct imaging of RecA nucleation and growth on single molecules of SSB-coated ssDNA.

Escherichia coli RecA is the defining member of a ubiquitous class of DNA strand-exchange proteins that are essential for homologous recombination, a pathway that maintains genomic integrity by repair...

Clinical Trials [ 728 Associated Clinical Trials listed on BioPortfolio]

Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation

PCI (optimal catheter-based coronary revascularization) + intensive medical therapy is superior to intensive medical therapy alone using the combined endpoint of all-cause mortality or non...

Does Follow-up With Serum Beta Human Chorionic Gonadotropin (BhCG) Simplify Medical Abortion?

The purpose of this study is to evaluate if BhCG testing to determine the completion of medical abortion simplifies the medical abortion protocol. Investigators hypothesize that women rand...

The Impact of Internationalize Medical Services to localPeople Seeking Medical Care

Recently The Department of Health of Taiwan has launched the "Internationalize Medical Services Flagship Program", expecting to promote Taiwan's high-quality of medical services to the int...

Development and Evaluation of a Medical Intervention for Early Childhood Caries

This study aimed to evaluate the effect of three forms of continuing medical education (CME) on provision of preventive dental services to Medicaid-enrolled children by medical personnel i...

Clinical Evaluation of the Interlace Medical Hysteroscopic Morcellator

This study assesses the effectiveness of intrauterine fibroid and polyp removal using the Interlace Medical 1st generation hysteroscopic morcellator device based on a retrospective review...

Companies [ 996 Associated Companies listed on BioPortfolio]

ReCor Medical, Inc.

Founded in 2009, ReCor is a private venture-backed, early-stage company developing novel therapeutic ultrasound catheter technology. ReCor is backed by European and U.S. investors...

ReCor Medical

Privately held ReCor Medical, based in Ronkonkoma, N.Y., and Paris, France, was founded in July 2009 by CEO Mano Iyer, Prof. Jacques Séguin, and Sofinnova Partners, to revoluti...

The Medical Affairs Company LLC

The Medical Affairs Company LLC is a full service Contract Medical Organization that provides pharmaceutical, biotechnology, and medical device industry clients a wide array of outsourcing capabil...

Medical Brands

Headquartered in Amsterdam, Netherlands, Medical Brands provides consumers with solutions in the OTC to everyday medical problems. Medical Brands develops patents, registers and p...

MedBio Publications Inc.

MedBio Publications provides 5 key services: medical writing, medical editing, medical translation, medical illustration, and medical publishing. Our clients are primarily national and international m...